Trofinetide and Simvastatin: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 4, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Trofinetide
Simvastatin
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Here's what's going on. Trofinetide (Daybue) can mildly slow down a liver enzyme called CYP3A that your body uses to break down simvastatin (Zocor). When that enzyme works slower, more simvastatin can build up in your body than usual.
Higher simvastatin levels can raise the chance of statin side effects, especially muscle aches or weakness. It's worth noting this is based mostly on theory, not on lots of real-world cases with these two drugs together. The good news is this is very manageable. Keep taking both exactly as prescribed, and let your pharmacist or doctor know so they can watch you a little more closely and adjust things if needed.
Mechanism: Trofinetide is a weak CYP3A inhibitor; simvastatin is a sensitive CYP3A4 substrate. Reduced simvastatin metabolism may increase its exposure (AUC/Cmax) and raise the risk of statin toxicity (myalgia, myopathy, rarely rhabdomyolysis).
- Direction: increased simvastatin effect/toxicity.
- Magnitude: not directly studied; a probe substrate (loperamide) showed ~1.73-fold AUC and ~1.95-fold Cmax increases.
- Evidence: theoretical.
- Onset: unspecified.
Management: Monitor for muscle symptoms and unexplained CK elevation. Dose may need individualization by the care team; consider staggered administration or an alternative statin if clinically indicated.
What happens
Increased CYP3A substrate exposure and an increased risk of CYP3A substrate-related toxicities
Interaction Deep Dive
When trofinetide (a weak CYP3A inhibitor) is taken alongside sensitive CYP3A substrates, exposure to those substrates can rise, potentially elevating the likelihood of adverse reactions tied to the sensitive CYP3A substrates. For sensitive CYP3A substrates in which even small increases in exposure could trigger serious adverse reactions, close monitoring is warranted during combined use with trofinetide. Data from a drug interaction study showed that giving trofinetide 12,000 mg twice daily together with loperamide 4 mg (a moderately sensitive CYP3A substrate) raised the loperamide AUC 1.73-fold and its Cmax 1.95-fold. When trofinetide was given 2 hours ahead of loperamide, the loperamide AUC rose 1.22-fold and the Cmax rose 1.44-fold12.
Why it happens (mechanism)
Inhibition of CYP3A substrate metabolism by trofinetide
How to manage this interaction
This is manageable with your care team. Continue taking both trofinetide and simvastatin exactly as prescribed unless your prescriber tells you otherwise.
- Your team may monitor you more closely for statin side effects while you take these together.
- Your simvastatin dose may need to be adjusted and individualized by your care team.
- Report new or worsening muscle pain, tenderness, weakness, or dark urine promptly.
- Ask your pharmacist whether spacing the doses apart or a different statin is a better fit for you.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) In a study evaluating drug interactions, giving trofinetide 12,000 mg twice daily together with loperamide 4 mg (a moderately sensitive CYP3A substrate) raised the AUC of loperamide by 1.73-fold and the Cmax by 1.95-fold. When trofinetide was given 2 hours before loperamide, the AUC of loperamide rose by 1.22-fold and the Cmax by 1.44-fold 12.
Common questions
Can I take Trofinetide and Simvastatin together?
Trofinetide can raise simvastatin levels and increase the chance of muscle-related statin side effects, so keep taking both as prescribed but tell your pharmacist or doctor so they can monitor you and adjust the dose if needed. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Trofinetide and Simvastatin interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Trofinetide and Simvastatin interaction managed?
This is manageable with your care team. Continue taking both trofinetide and simvastatin exactly as prescribed unless your prescriber tells you otherwise. Your team may monitor you more closely for statin side effects while you take these together. Your simvastatin dose may need to be adjusted and individualized by your care team. Report new or worsening muscle pain, tenderness, weakness, or dark… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Trofinetide or Simvastatin need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (2)
- Product Information: DAYBUE® oral solution, trofinetide oral solution. Acadia Pharmaceuticals Inc (per FDA), San Diego, CA, 2025. DailyMed
- Product Information: DAYBUE® STIX powder for oral solution, trofinetide powder for oral solution. Acadia Pharmaceuticals Inc (per FDA), San Diego, CA, 2025. DailyMed
Keep reading about Trofinetide
Keep reading about Simvastatin
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist